APA (7th ed.) Citation

X, F., D, G., AMS, C., ZY, P., CS, Y., SE, G., . . . WYK, H. (2018). Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24(10), 1971. https://doi.org/10.1016/j.bbmt.2018.05.029

Chicago Style (17th ed.) Citation

X, Fan, et al. "Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 10 (2018): 1971. https://doi.org/10.1016/j.bbmt.2018.05.029.

MLA (9th ed.) Citation

X, Fan, et al. "Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 24, no. 10, 2018, p. 1971, https://doi.org/10.1016/j.bbmt.2018.05.029.